Inovio Treats First Patient in Immuno-Oncology Study for Advanced or Metastatic Bladder Cancer in Combination with Roche/Genentech's Atezolizumab
Stock Information for Inovio Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.